MENU
REGN
AS OF
Nov 13, 04:59 PM (EDT)
Price
$695.46
Change
+$13.74 (+2.02%)
Capitalization
71.65B
78 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Regeneron Pharmaceuticals (REGN) Earnings Date & Reports

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

REGN is expected to report earnings to fall 10.74% to $10.56 per share on January 30

Regeneron Pharmaceuticals REGN Stock Earnings Reports
Q4'25
Est.
$10.56
Q3'25
Beat
by $2.19
Q2'25
Beat
by $4.39
Q1'25
Missed
by $0.26
Q4'24
Beat
by $0.80
The last earnings report on October 28 showed earnings per share of $11.83, beating the estimate of $9.64. With 539.45K shares outstanding, the current market capitalization sits at 71.65B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
REGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. REGN showed earnings on October 28, 2025. You can read more about the earnings report here.
View AI-Driven Trading for REGN
A.I. Advisor
published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com